Michael Finamore
Vorstandsvorsitzender bei Gemini Pharmaceuticals, Inc.
Ursprung des Netzwerks ersten Grades von Michael Finamore
| Einheit | Art der Einheit | Industrie | |
|---|---|---|---|
Gemini Pharmaceuticals, Inc.
 Gemini Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Gemini Pharmaceuticals, Inc. manufactures pharmaceutical products. It offers dietary supplements, herbs and nutritional products. The firm's products include male and female libido enhancers, breast enhancers, smoking cessation supplements, weight loss supplements, multivitamins, digestive aids and painkillers towards pets. Gemini Pharmaceuticals was founded in 1982 and is headquartered in Commack, NY.
5
| Private Company | Pharmaceuticals: Major | 5 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Michael Finamore
| Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
|---|---|---|---|
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Biotechnology | Corporate Officer/Principal | |
| KINTARA THERAPEUTICS, INC. | Biotechnology | Director/Board Member | |
| Adelphi University | College/University | Undergraduate Degree | |
| New York University | College/University | Undergraduate Degree | |
| University of Catania | College/University | Doctorate Degree | |
| University of California | College/University | Corporate Officer/Principal | |
Catalio Capital Management LP
 Catalio Capital Management LP Investment ManagersFinance Catalio Capital Management LP (Catalio Capital) is a venture capital firm founded in 2020 by George Petrocheilos and Dr. Jacob Vogelstein. The firm is headquartered in New York. | Investment Managers | Private Equity Investor | |
| Theia Therapeutics, Inc. | Founder | ||
Inflammasome Therapeutics, Inc.
 Inflammasome Therapeutics, Inc. BiotechnologyHealth Technology Inflammasome Therapeutics, Inc. develops therapies for prevalent and degenerative diseases. The American company was founded in 2016 by Jayakrishna Ambati and Paul Ashton. Paul Ashton has been the CEO since 2016. | Biotechnology | Director/Board Member |
Statistik
International
| Vereinigte Staaten | 9 |
| Italien | 2 |
Sektoral
| Consumer Services | 5 |
| Health Technology | 4 |
| Finance | 2 |
Operativ
| Corporate Officer/Principal | 3 |
| Sales & Marketing | 2 |
| Undergraduate Degree | 2 |
| Director/Board Member | 2 |
| President | 1 |
Am stärksten vernetzte Beziehungen
| Insiders | |
|---|---|
| Napoleone Ferrara | 8 |
| Joni Foley | 3 |
| Andrew Finamore | 1 |
| Emma Ebere | 1 |
| John Donovan | 1 |
- Börse
- Insiders
- Michael Finamore
- Unternehmensverbindungen
